Rat's Rant: What's hot, what's not and... the Bali anniversary
Oct 2, 2019
Oct 2, 2019 |
Actinogen closed up 466% to finish at 5.1c on $15.8 million stock traded. The company announced results from the XanaHES (Xanamem in Healthy Elderly Subjects) trial. The results demonstrate a significant improvement in cognition in trial participants dosed with Xanamem 20mg daily for 12 weeks, compared to placebo.
Rat's Rant: What's hot, what's not and ... The Canberra Raiders
Oct 1, 2019
Oct 1, 2019 |
Change Financial Limited (ASX:CCA) closed up 332% to finish at 54c on $11.2 million stock traded on the back of the successful completion of the build of its innovative payments and card issuing platform marking a key milestone for the company.